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CASE PRESENTATION
A 30-year-old Caucasian male on chronic hemodialysis
presents with a 4-day history of right flank pain
accompanied by fever, nausea, and anorexia.
On physical examination, he had a heart rate of 100
beats per minute and a blood pressure of 147/95 mm Hg.
The abdomen was soft. There was no tenderness or
guarding over the allograft, and lymph nodes were not
enlarged. His remaining examination was unremarkable.
Blood and urine cultures were negative. The patient
had undergone ultrasonographic examination of the
allograft every year since 1998 with evidence of simple
cysts in the parenchyma (Figure 1a) and a persistent fluid
collection adjacent to the lower pole representing a
lymphocele. A CT scan of the abdomen showed two
sub-centimeter low-density lesions within the enlarged
right transplanted kidney, suspicious for an infectious
or neoplastic process. A persistent and stable right lower
quadrant lymphocele was also present. Aspiration of
the lymphocele yielded sterile fluid without evidence of
infection. A transplant nephrectomy was performed.
TRANSPLANT NEPHRECTOMY FINDINGS
The right transplanted kidney weighed 105 g. On gross
examination, the capsule had multiple hemorrhagic adhe-
sions. The sectioned parenchyma had five small smooth-
walled cysts ranging from 0.2 to 0.7 cm across. Also seen in
the cortex, in several serial sections of the renal paren-
chyma, were two small solid tan nodules with a maximum
cross-sectional diameter of 1.1 cm. One of the nodules was
cystic and partly hemorrhagic. Light microscopic examina-
tion of the hemorrhagic and cystic nodule was characteristic
of a renal cell carcinoma (RCC), clear cell type (Figure 1b).
The second solid nodule was a papillary RCC with
extension into the surrounding parenchyma. Micro-
scopically, both tumors were high grade (Fuhrman nuclear
grade of 3/4). The tumors were confined to the kidney
parenchyma and did not extend into the perirenal fat.
Lymphatic or vascular invasion was not present. Two smaller
lesions categorized as papillary adenomatous proliferations
were also seen (Figure 1c). Simple cystic spaces lined by
flattened epithelial cells were present in the cortex. Focal
proliferation and tufting of the lining epithelial cells were
seen. Review of a section from non-neoplastic renal
parenchyma showed 63 glomeruli, of which 34 were globally
sclerosed and 3 glomeruli had segmental sclerosis of the
tuft with adherence to the Bowman’s capsule. The viable
glomeruli showed focally prominent hypercellularity, with
increase in mesangial cells and swollen endothelial cells
within the capillaries. There were 11 cellular, 6 fibrocellular,
and 4 fibrous crescents. Active interstitial inflammation was
noted involving more than 80% of the parenchyma, and was
composed of predominantly lymphocytes, occasional plasma
cells, and polymorphonuclear cells. Tubulitis was present
focally. More than 50% of the sample showed interstitial
fibrosis and tubular atrophy. Many arteries and arterioles
revealed extensive endothelitis and infiltration of the
subintima by foam cells. Immunofluorescence microscopy
studies showed diffuse granular deposition of IgA (3þ /4þ ),
IgG (1þ /4þ ), C3 (2þ /4þ ), and IgM (2þ /4þ ) in the
mesangial areas of the viable glomeruli. Electron microscopic
examination was characterized by electron-dense deposits
present in the mesangium, with rare dense deposits noted in
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the subendothelial space of the para mesangial peripheral
capillary wall. The visceral epithelial cells were well preserved.
No evidence of malignancy was present in the tissue
submitted for ultrastructural studies.
A pathological diagnosis of clear cell and papillary RCC
with multiple papillary adenomas in a background of
acquired cystic kidney disease (ACKD) was made. A focal
proliferative and crescentic recurrent IgA nephropathy with
acute vascular rejection and chronic allograft changes was
also present.
CLINICAL DIAGNOSIS
De novo multifocal RCC (clear cell type and papillary RCC
with multiple papillary adenomas) in the allograft with acute
or chronic allograft rejection and recurrent IgA nephropathy.
CLINICAL FOLLOW-UP
A follow-up CT scan of the abdomen with contrast
was performed. This showed no evidence of metastatic renal
carcinoma. The patient had repeated episodes of hypertensive
crisis and underwent a left native nephrectomy in May 2007.
The nephrectomy specimen showed an end-stage kidney with
no recognizable glomeruli, ACKD, and severe arteriosclerosis.
There was no evidence of tumor. Currently, our patient is on
chronic hemodialysis.
DISCUSSION
As transplant outcomes have improved over the past four
decades, we observe the emerging importance of recurrent
and or de novo disease as a cause of allograft failure.1 IgA
nephropathy, recurrent and in the allograft, has been
reviewed extensively before.2 Malignancies arising in the set-
ting of renal transplantation are recognized as complications
of the allograft.3,4 RCC (after malignancies of the skin
and lips, post-transplant lymphoproliferative disorders and
Kaposi’s sarcoma) is one of the most frequently occurring
post-transplantation malignancies.3 Our case demonstrated
both clear cell type and papillary RCC and multiple papillary
adenomas. The relevance of early detection, risk factors,
prognostic parameters, and management strategies for RCC
in the allograft will be discussed.
RCCs in renal transplant recipients occur most frequently
in the native (diseased) kidneys; however, in a large study
by Penn4 who evaluated primary kidney tumors before and
after renal transplantation, RCCs in the allograft were found
to account for 10% of transplant-associated RCCs and
occurred 2–258 months after transplantation. The classic
triad of symptoms, namely hematuria, abdominal pain, and
flank pain, observed in as many as 40% of RCCs is not a
defining feature of transplant RCC. Data from the Cincinnati
Transplant Tumor Registry showed that 24% of renal
carcinomas were discovered incidentally at the time of
nephrectomy for other causes, surgery associated with other
diseases, or at autopsy.3 Clinical manifestations of transplant
associated RCC are generally vague. Patients may be
asymptomatic and present with either hematuria or protei-
nuria or they may complain of abdominal discomfort or have
fever.5 Tumors may also be detected when abdominal
ultrasound is performed routinely as part of post-transplant
follow-up.6 In the few cases where abdominal ultrasound
were not routinely carried out after transplant, the tumors
were large and had already metastasized.7
There are several risk factors for malignancies developing
after renal transplantation (Table 1). Obesity, tobacco
consumption, and frequent pyelonephritis are factors known
to predispose to RCC.8,9 In transplant recipients, the role of
prolonged immunosuppression and oncogenic viruses might
also be considered.10,11 It has been observed that non-
transplant patients on high-dose immunosuppressants, such
as those with rheumatoid arthritis, systemic lupus erythemo-
tosus or dermatomyositis, may also develop de novo malig-
nancies.12 Although the relationship between tumorigenesis
and immunosuppression is not completely understood,
Figure 1 | Ultrasound and renal pathology. (a) The cystic lesions
in the ultrasound of the renal allograft. (b) The tumor has distinctive
nests of clear cells with atypical nuclei set in a partly hemorrhagic
background (hematoxylin and eosin, original magnification
 25 high power field). (c) Closely packed nests of papillary
structures lined by small cells with regular nuclei (hematoxylin
and eosin, original magnification  25 high power field).
Table 1 | Risk factors for malignancies after renal
transplantation
Conventional risk factors
Obesity
Analgesic abuse
Smoking
Immunosuppression
Triple drug immunosuppression
Genetic risk factors
von Hippel–Lindau’s disease
Chronic viral infections
BK virus
Acquired cystic kidney disease
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modifications of the host immune response and a lack of
sufficient tumor surveillance may play a role. Although chronic
viral infections have not been directly implicated with RCC, a
recent report11 of renal allograft with BK virus DNA in a RCC,
including in the metastases, adds to evidence that viruses may
play a role in cancers of the kidney and urinary tract. The
processes involved with viral-induced tumorigenesis include
escape from apoptosis and evasion of the host immune system.13
Genetic factors are known to predispose to RCC. The frequency
of RCC is increased in patients with von Hippel–Lindau
disease.14 Among those with chronic renal failure and dialysis,
ACKD has long been associated with renal tumors.15–17 In
a recent study of renal transplant recipients by Schwarz et al.,18
the prevalence of RCC in those with ACKD was between 20
and 54.4% among patients with complex cysts. The cysts may
be simple or atypical with papillary or cribriform patterns of
proliferation. Cheuk et al.19 have demonstrated, by interphase
cytogenetics, that there are gains of chromosome 7, 12, 17, and
20 in the proliferative tufts of these atypical cysts. These
chromosomal aberrations suggest that atypical epithelial proli-
feration in ACKD represent early neoplastic lesions. Recognizing
the neoplastic potential of ACKD, screening kidney transplant
candidates for ACKD and kidney cancer is recommended by the
North American Transplantation Society.20
The classification of renal cell neoplasms has been
extensively studied and a standardized nomenclature adopted
(Table 2).21 Although this system is based on a combination
of genetic, histological, and immunohistological features, in
most cases accurate classification can be based on histological
features alone. The histological patterns of RCC observed in
our case are the conventional clear cell and papillary type
RCC with multiple papillary adenomata.
Papillary adenoma is the most common neoplasm of the
renal tubular epithelium and is a frequent incidental finding
in adult kidneys. Most are o3 mm in size. Lesions o5 mm
are usually papillary adenomas. There are no reliable
cytologic criteria to distinguish adenomata from small RCCs.
The benign nature of these lesions is inferred from their
high frequency compared with that of progressive papillary
carcinoma. The papillary carcinoma is the second most
frequent carcinoma and accounts for 10–15% of RCCs. These
cancers have a discernible papillary architecture. Genetic
abnormalities are frequent in this subset with trisomies of
chromosomes 3q, 7, 12, 16, 17, and 20 and loss of the
Y chromosome.21 In the literature, malignancies arising in
dialysis and transplant patients are more frequently papillary
carcinomas.22 Although this might be due to immuno-
suppression causing more frequent genetic mutations, Hoshida
et al.23 propose that the papillary pattern of proliferation is
transient and might be induced by dialysis-related factors.
The conventional clear cell carcinoma is the most common
cancer of the renal tubular epithelium. Clear cell carcinomas
are principally composed of clear cells with occasional cells
having an eosinophilic cytoplasm. Clear cell carcinomas have
both solid and cystic areas. They are frequently associated
with the deletion of genetic material in chromosome 3p.21
Multifocal RCCs of the allograft, as observed in our case
presentation, have been reported previously,22 but remain a
rare occurrence. The frequency of multiple RCCs in transplant
and dialysis patients is well documented but uncommon.
Hoshida et al.23 observed the frequency of multifocal tumors
in transplant (and dialysis) patients to be up to 27%, which
was 10 times higher than sporadic RCCs. RCCs occurring in
the setting of transplant and dialysis share several clinico-
pathological features, such as small size, multiplicity, papillary
type of RCC, and the presence of ACKD.
The morbidity and graft failure related to allograft tumors
warrants early diagnosis and appropriate management. Roupreˆt
et al.7 strongly recommend a strategy of annual ultrasonography
of the allograft. In the majority of transplant centers, as in ours,
annual CT or ultrasound surveillance of the native allograft is
routinely performed to detect de novo malignancy post-
transplantation. In our case, despite routine annual ultrasound,
the small ill-defined lesions were characterized only on CT
studies. This is because, ultrasound has a limited sensitivity
(67%) in detecting tumors that are o3 cm in diameter.24
Because primary tumors of the allograft are still quite rare,
there is no consensus on the management of these patients.
Ribal et al.24 have proposed nephron sparing surgery of the
allograft as one approach for tumor removal because it allows
preservation of graft function. Nephron sparing surgery can be
performed without significant impairment of graft function in
tumorso4 cm in diameter (classified as T1a). Indeed, Barama
et al.6 recommended nephron sparing surgery for incidental
RCC to prevent an immediate return to dialysis for patients.
Transplant nephrectomy is an alternative approach. In our
patient, the multifocal nature of the tumor as well as advanced
chronic parenchymal damage and graft dysfunction argued
against nephron sparing surgery and our patient underwent
allograft nephrectomy.
In summary, our patient had an allograft complicated
with recurrent disease and multifocal RCC. Although
malignancies in the setting of transplantation are far more
frequent in the native kidneys, in our case, the tumor
involved the allograft. ACKD, a well-known risk factor for
RCC in the kidney, was seen in both the native kidneys and in
the allograft. Our case presentation underscores the impor-
tance of screening for renal cell neoplasms in the transplant
allograft. Annual CT should be considered as the preferred
screening modality.
Table 2 | Classification of renal cell neoplasms
Benign neoplasms
Renal cortical adenomas
Oncocytomas
Metanephric adenoma
Malignant neoplasms
Transitional cell carcinoma
Conventional (clear cell) renal cell carcinoma
Papillary renal cell carcinoma
Chromophobe renal cell carcinoma
Collecting duct carcinoma
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